Pyridostigmine enhances glutamatergic transmission in hippocampal CA1 neurons

Experimental Neurology

Volumn 179, Issue 2, 2003, Pages 181-187

  Pavlovsky, Lev ^a   Browne, R Orie ^a   Friedman, Alon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acetylcholine; Acetylcholinesterase inhibitors; Glutamate; Muscarinic receptors; Presynaptic modulation; Synaptic transmission

Indexed keywords

ATROPINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PYRIDOSTIGMINE; TETRODOTOXIN;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GABAERGIC TRANSMISSION; HIPPOCAMPUS; INTRACELLULAR RECORDING; MALE; MOUSE; NERVE CELL; NERVE CONDUCTION; NERVE EXCITABILITY; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; ATROPINE; CHOLINESTERASE INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; HIPPOCAMPUS; MEMBRANE POTENTIALS; MICE; MUSCARINIC ANTAGONISTS; NEURONS; PATCH-CLAMP TECHNIQUES; PYRIDOSTIGMINE BROMIDE; SYNAPTIC TRANSMISSION; TETRODOTOXIN;

EID: 0037331337     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(02)00016-X     Document Type: Article

References (54)

1. Alkondon M., Pereira E.F., Barbosa C.T., Albuquerque E.X. Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J. Pharmacol. Exp. Ther. 283:1997;1396-1411.
2. Aquilonius S.M., Hartvig P. Clinical pharmacokinetics of cholinesterase inhibitors. Clin. Pharmacokinet. 11:1986;236-249.
3. Auerbach J.M., Segal M. A novel cholinergic induction of long-term potentiation in rat hippocampus. J. Neurophysiol. 72:1994;2034-2040.
4. Benardo L.S., Prince D.A. Cholinergic excitation of mammalian hippocampal pyramidal cells. Brain Res. 249:1982;315-331.
5. Benardo L.S., Prince D.A. Ionic mechanisms of cholinergic excitation in mammalian hippocampal pyramidal cells. Brain Res. 249:1982;333-344.
6. Blanton M.G., Lo Turco J.J., Kriegstein A.R. Whole cell recording from neurons in slices of reptili an and mammalian cerebral cortex. J. Neurosci. Methods. 30:1989;203-210.
7. Coggan J.S., Purnyn S.L., Knoper S.R., Kreulen D.L. Muscarinic inhibition of two potassium currents in guinea-pig prevertebral neurons differentiation by extracellular cesium . Neuroscience. 59:1994;349-361.
8. Cole A.E., Nicoll R.A. Characterization of a slow cholinergic post-synaptic potential recorded in vitro from rat hippocampal pyramidal cells. J. Physiol. (London). 352:1984;173-188.
9. Descarries L., Gisiger V., Steriade M. Diffuse transmission by acetylcholine in the CNS. Progr. Neurobiol. 53:1997;603-625.
10. Esposito P., Gheorghe D., Kandere K., Pang X., Connolly R., Jacobson S., Theoharides C.T. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain. Res. 888:2001;117-127.
11. + current and slow cumulative spike adaptation in mouse and guinea-pig neocortical neurones in slices. J. Physiol. (London). 493:1996;83-97.
12. Friedman A., Kaufer D., Shemer J., Hendler I., Soreq H., Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nature Med. 2:1996;1382-1385.
13. Gahwiler B.H., Brown D.A. Muscarine affects calcium-currents in rat hippocampal pyramidal cells in vitro. Neurosci. Lett. 76:1987;301-306.
14. Grauer E., Alkalai D., Kapon J., Cohen G., Raveh L. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol. Appl. Pharmacol. 164:2000;301-304.
15. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
16. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391:1981;85-100.
17. Jones S., Yakel J.L. Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J. Physiol. (London). 504:1997;603-610.
18. Ilouz N., Branski L., Parnis J., Parnas H., Linial M. Depolarization affects the binding properties of muscarinic acetylcholine receptors and their interaction with proteins of the exocytic apparatus. J. Biol. Chem. 274:1999;29519-29528.
19. Iwasaki Y., Wakata N., Kinoshita M. Parkinsonism induced by pyridostigmine. Acta Neurol. Scand. 78:1988;236.
20. Kaufer D., Friedman A., Seidman S., Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature. 393:1998;373-377.
21. Kobayashi M., Ohno M., Shibata S., Yamamoto T., Watanabe S. Concurrent blockade of beta-adrenergic and muscarinic receptors suppresses synergistically long-term potentiation of population spikes in the rat hippocampal CA1 region. Brain. Res. 777:1997;242-246.
22. Liao D., Hessler N.A., Malinow R. Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice. Nature. 375:1995;400-404.
23. Liao D., Scannevin R.H., Huganir R. Activation of silent synapses by rapid activity-dependent synaptic recruitment of AMPA receptors. J. Neurosci. 21:2001;6008-6017.
24. Ling D.S., Benardo L.S. Properties of isolated GABAB-mediated inhibitory postsynaptic currents in hippocampal pyramidal cells. Neuroscience. 63:1994;937-944.
25. Lisak R.P. Myasthenia gravis. Curr. Treat. Options Neurol. 1:1999;239-250.
26. Loewenstein-Lichtenstein Y., Schwarz M., Glick D., Norgaard-Pedersen B., Zakut H., Soreq H. Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers. Nature Med. 1:1995;1082-1085.
27. Madison D.V., Lancaster B., Nicoll R.A. Voltage clamp analysis of cholinergic action in the hippocampus. J. Neurosci. 7:1987;733-741.
28. Markram H., Segal M. Acetylcholine potentiates responses to N-methyl-D-aspartate in the rat hippocampus. Neurosci. Lett. 113:1990;62-65.
29. Markram H., Segal M. The inositol 1,4,5-trisphosphate pathway mediates cholinergic potentiation of rat hippocampal neuronal responses to NMDA. J. Physiol. (London). 447:1992;513-533.
30. McQuiston A.R., Madison D.V. Muscarinic receptor activity has multiple effects on the resting membrane potentials of CA1 hippocampal interneurons. J. Neurosci. 19:1999;5693-5702.
31. Meshorer E., Erb C., Gazit R., Pavlovsky L., Kaufer D., Friedman A., Glick D., Ben-Arie N., Soreq H. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science. 295:2002;508-512.
32. Messamore E., Warpman U., Ogane N., Giacobini E. Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex. Neuropharmacology. 32:1993;745-750.
33. Mesulam M.M., Geula C. Acetylcholinesterase-rich neurons of the human cerebral cortex cytoarchitectonic and ontogenetic patterns of distribution . J. Comp. Neurol. 306:1991;193-220.
34. Moretto, A., 1998. Experimental and clinical toxicology of anticholinesterase agents. Toxicol. Lett. 102-103, 509-513.
35. Mrzljak L., Levey A.I., Goldman-Rakic P.S. Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex morphological evidence for cholinergic modulation of excitatory neurotransmission . Proc. Natl. Acad. Sci. USA. 90:1993;5194-5198.
36. Mrzljak L., Pappy M., Leranth C., Goldman-Rakic P.S. Cholinergic synaptic circuitry in the macaque prefrontal cortex. J. Comp. Neurol. 357:1995;603-617.
37. Mrzljak L., Levey A.I., Belcher S., Goldman-Rakic P.S. Localization of the m2 muscarinic acetylcholine receptor protein and mRNA in cortical neurons of the normal and cholinergically deafferented rhesus monkey. J. Comp. Neurol. 390:1998;112-132.
38. Narahashi T. Neuronal ion channels as the target sites of insecticides. Pharmacol. Toxicol. 79:1996;1-14.
39. Noraberg J., Gramsbergen J.B.P., Fonnum F., Zimmer J. Trimethyltin (TMT) neurotoxicity in organotypic rat hippocampal slice cultures. Brain Res. 783:1998;305-315.
40. Perry E., Walker M., Grace J., Perry R. Acetylcholine in mind a neurotransmitter correlate of consciousness? Trends. Neurosci. 22:1999;273-280.
41. Qian J., Saggau P. Presynaptic inhibition of synaptic transmission in the rat hippocampus by activation of muscarinic receptors involvement of presynaptic calcium influx . Br. J. Pharmacol. 122:1997;511-519.
42. Scanziani M., Gahwiler B.H., Thompson S.M. Presynaptic inhibition of excitatory synaptic transmission by muscarinic and metabotropic glutamate receptor activation in the hippocampus are Ca2+ channels involved? Neuropharmacology. 34:1995;1549-1557.
43. Seeger T., Alzheimer C. Muscarinic activation of inwardly rectifying K(+) conductance reduces EPSPs in rat hippocampal CA1 pyramidal cells. J. Physiol. 535:2001;383-396.
44. Segal M. Multiple action of acetylcholine at a muscarinic receptor studied in the rat hippocampal slice. Brain Res. 246:1982;77-87.
45. Sharabi Y., Danon Y.L., Berkenstadt H., Almog S., Mimouni-Bloch A., Zisman A., Dani S., Atsmon J. Survey of symptoms following intake of pyridostigmine during the Persian Gulf war. Isr. J. Med. Sci. 27:1991;656-658.
46. Sokolov M.V., Kleschevnikov A.M. Atropine suppresses associative LTP in the CA1 region of rat hippocampal slices. Brain Res. 672:1995;281-284.
47. Solberg Y., Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol. Sci. 18:1997;183-185.
48. Sternfeld M., Ming G., Song H., Sela K., Timberg R., Poo M., Soreq H. Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J. Neurosci. 18:1998;1240-1249.
49. Sudweeks S.N., Yakel J.L. Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J. Physiol. 527:2000;515-528.
50. Takumi Y., Ramirez-Leon V., Laake P., Rinvik E., Ottersen O.P. Different modes of expression of AMPA and NMDA receptors in hippocampal synapses. Nature Neurosci. 2:1999;618-624.
51. Tomkins O., Kaufer D., Shelef I., Golan H., Reichenthal E., Soreq H., Friedman A. Frequent blood-brain-barrier disruption in the human cerebral cortex. Cell. Mol. Neurobiol. 21:2001;675-691.
52. Traub R.D., Borck C., Colling S.B., Jefferys J.G. On the structure of ictal events in vitro. Epilepsia. 37:2001;879-891.
53. Tsubokawa H., Ross W.N. Muscarinic modulation of spike backpropagation in the apical dendrites of hippocampal CA1 pyramidal neurons. J. Neurosci. 17:1997;5782-5791.
54. Victor M., Ropper A.H. Adams and Victor's Principles of Neurology. 2001;McGraw-Hill, New York.